Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TVGN-489 by Tevogen Bio for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
TVGN-489 is under clinical development by Tevogen Bio and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to...